The Final Diagnosis: Retinoblastoma or Pseudoretinoblastoma
Author:
Publisher
SLACK, Inc.
Subject
Ophthalmology,General Medicine,Pediatrics, Perinatology and Child Health
Reference18 articles.
1. Retinoblastoma
2. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe*1Advantages of birth cohort analysis
3. Incidence of retinoblastoma in the USA: 1975-2004
4. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death
5. Presenting signs of retinoblastoma
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanotechnology-based strategies overcoming the challenges of retinoblastoma: a comprehensive overview and future perspectives;Future Journal of Pharmaceutical Sciences;2024-02-09
2. Retinoblastoma treatment in a Brazilian population. Presentation and long‐term results;Cancer Medicine;2024-01-19
3. Conservative treatment using laser diode and systemic chemotherapy for early‐stage bilateral retinoblastoma: A 14‐year prospective cohort study;Cancer Reports;2023-10-17
4. The p53/HMGB1 Complex Regulates Cell Autophagy and Apoptosis in Retinoblastoma;J BIOL REG HOMEOS AG;2023
5. Clinical characteristics, treatment and prognosis of infants with retinoblastoma: a multicenter, 10-year retrospective analysis;BMC Pediatrics;2023-05-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3